Lupin’s Indore Facility Fails To Clear Regulatory Test Again
General views of drugs (Photographer: Brent Lewin/Bloomberg)

Lupin’s Indore Facility Fails To Clear Regulatory Test Again

Lupin Ltd. again received six observations from the U.S. health regulator for its Indore facility, a move that may cause disruption in supplies and delay future drug approvals.The U.S. Food and Dru...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.